CAS: 1443530-05-9
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Rogaratinib REF: 3D-THC53005CAS: 1443530-05-9 | Min. 95% | 234.00 €~1,684.00 € | Wed 18 Dec 24 |
 | Rogaratinib REF: TM-T16781CAS: 1443530-05-9 | 99.54% | 147.00 €~1,734.00 € | Mon 27 Jan 25 |
Rogaratinib
CAS:1443530-05-9
Rogaratinib is a kinase inhibitor drug that is used to treat hyperproliferative disease, such as …
Formula:
C23H26N6O3S
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
466.56 g/mol
Ref: 3D-THC53005
| 1mg | 234.00 € | ||
| 2mg | 352.00 € | ||
| 5mg | 626.00 € | ||
| 10mg | 895.00 € | ||
| 25mg | 1,684.00 € |
Estimated delivery in United States, on Wednesday 18 Dec 2024
Rogaratinib
CAS:1443530-05-9
Rogaratinib (BAY1163877) is an aberrant inhibitor of fibroblast growth factor receptor (FGFR).
Formula:
C23H26N6O3S
Purity:
99.54%
Color and Shape:
Solid
Molecular weight:
466.56
Ref: TM-T16781
| 1mg | 147.00 € |
Estimated delivery in United States, on Monday 27 Jan 2025
